All Stories

  1. The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers

    Article • Genetics in Medicine, June 2015, Springer Science + Business Media

    Dr Juul T Wijnen

  2. Splicing analysis for exonic and intronic mismatch repair gene variants associated with Lynch syndrome confirms high concordance between minigene assays and patient RNA analyses

    Article • Molecular Genetics & Genomic Medicine, April 2015, Wiley

    Dr Juul T Wijnen, Master Heleen M. van der Klift

  3. Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab

    Article • Biology of Blood and Marrow Transplantation, March 2015, Elsevier

    Dr Juul T Wijnen

  4. Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk

    Article • Journal of Clinical Oncology, December 2014, American Society of Clinical Oncology (ASCO)

    Dr Juul T Wijnen

  5. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer

    Article • European Journal of Human Genetics, November 2014, Springer Science + Business Media

    Dr Juul T Wijnen

  6. The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals

    Article • PLoS ONE, April 2014, PLOS

    Dr Juul T Wijnen, Sergi Castellvi-Bel

  7. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ

    Article • Journal of Experimental & Clinical Cancer Research, March 2014, Springer Science + Business Media

    Dr Juul T Wijnen

  8. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

    Article • Nature Genetics, December 2013, Springer Science + Business Media

    Dr Juul T Wijnen, Alexandra Martins

  9. The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients

    Article • Hereditary Cancer in Clinical Practice, December 2013, Springer Science + Business Media

    Dr Juul T Wijnen

  10. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

    Article • Journal of Medical Genetics, November 2013, BMJ

    Dr Juul T Wijnen

  11. Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis

    Article • Journal of Medical Genetics, November 2013, BMJ

    Dr Juul T Wijnen

  12. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

    Article • PLoS ONE, September 2013, PLOS

    Dr Juul T Wijnen, Dr Michael Hoffmeister, Fernando Fernández-Bañares

  13. Value-based healthcare in Lynch syndrome

    Article • Familial Cancer, May 2013, Springer Science + Business Media

    Dr Juul T Wijnen, Professor Aad Tibben

  14. CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

    Article • European Journal of Human Genetics, May 2013, Springer Science + Business Media

    Dr Juul T Wijnen

  15. Reply to Win and Jenkins

    Article • International Journal of Cancer, April 2013, Wiley

    Dr Juul T Wijnen

  16. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

    Article • PLoS Genetics, March 2013, PLOS

    Dr Juul T Wijnen

  17. Genetic modifiers of cancer risk in Lynch syndrome: a review

    Article • Familial Cancer, March 2013, Springer Science + Business Media

    Dr Juul T Wijnen

  18. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

    Article • Gut, February 2013, BMJ

    Dr Juul T Wijnen

  19. Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling

    Article • PLoS ONE, January 2013, PLOS

    Dr Juul T Wijnen

  20. Variants of Uncertain Significance inBRCA1andBRCA2assessment of in silico analysis and a proposal for communication in genetic counselling

    Article • Journal of Medical Genetics, December 2012, BMJ

    Dr Juul T Wijnen

  21. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

    Article • The Lancet Oncology, December 2012, Elsevier

    Dr Juul T Wijnen

  22. Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers

    Article • International Journal of Cancer, October 2012, Wiley

    Dr Juul T Wijnen

  23. Rare variants in XRCC2 as breast cancer susceptibility alleles: Table 1

    Article • Journal of Medical Genetics, October 2012, BMJ

    Dr Juul T Wijnen

  24. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome

    Article • European Journal of Human Genetics, September 2012, Springer Science + Business Media

    Dr Juul T Wijnen

  25. Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

    Article • PLoS ONE, June 2012, PLOS

    Dr Juul T Wijnen

  26. Insertion of an SVA element, a nonautonomous retrotransposon, inPMS2intron 7 as a novel cause of lynch syndrome

    Article • Human Mutation, April 2012, Wiley

    Dr Juul T Wijnen

  27. Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

    Article • Breast Cancer Research and Treatment, February 2012, Springer Science + Business Media

    Dr Juul T Wijnen

  28. MUTYH gene variants and breast cancer in a Dutch case–control study

    Article • Breast Cancer Research and Treatment, February 2012, Springer Science + Business Media

    Dr Juul T Wijnen

  29. A review of the genetic background and tumour profiling in familial colorectal cancer

    Article • Mutagenesis, January 2012, Oxford University Press (OUP)

    Dr Juul T Wijnen

  30. Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts

    Article • Hereditary Cancer in Clinical Practice, January 2012, Springer Science + Business Media

    Dr Juul T Wijnen

  31. 8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome

    Article • European Journal of Human Genetics, December 2011, Springer Science + Business Media

    Dr Juul T Wijnen

  32. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

    Article • The Lancet, December 2011, Elsevier

    Dr Juul T Wijnen

  33. Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors

    Article • Familial Cancer, November 2011, Springer Science + Business Media

    Dr Juul T Wijnen

  34. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

    Article • PLoS Biology, November 2011, PLOS

    Dr Juul T Wijnen

  35. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas

    Article • International Journal of Cancer, July 2011, Wiley

    Dr Juul T Wijnen

  36. Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

    Article • Cancer Epidemiology Biomarkers & Prevention, March 2011, American Association for Cancer Research (AACR)

    Dr Juul T Wijnen

  37. Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations

    Article • Clinical Genetics, February 2011, Wiley

    Dr Juul T Wijnen

  38. Novel MLH1 duplication identified in Colombian families with Lynch syndrome

    Article • Genetics in Medicine, January 2011, Springer Science + Business Media

    Dr Juul T Wijnen

  39. Leiden open variation database of the MUTYH gene

    Article • Human Mutation, October 2010, Wiley

    Dr Juul T Wijnen

  40. Peutz-Jeghers syndrome: a systematic review and recommendations for management

    Article • Gut, June 2010, BMJ

    Dr Juul T Wijnen, Dr Andrew D Beggs

  41. A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1

    Article • Human Mutation, March 2010, Wiley

    Dr Juul T Wijnen

  42. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer

    Article • Breast Cancer Research and Treatment, February 2010, Springer Science + Business Media

    Dr Juul T Wijnen

  43. Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy

    Article • Hereditary Cancer in Clinical Practice, January 2010, Springer Science + Business Media

    Dr Juul T Wijnen

  44. Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer

    Article • Genes Chromosomes and Cancer, January 2010, Wiley

    Dr Juul T Wijnen

  45. Quantification of sequence exchange events betweenPMS2andPMS2CLprovides a basis for improved mutation scanning of Lynch syndrome patients

    Article • Human Mutation, January 2010, Wiley

    Dr Juul T Wijnen

  46. Erratum: COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    Article • British Journal of Cancer, January 2010, Springer Science + Business Media

    Dr Juul T Wijnen

  47. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    Article • British Journal of Cancer, November 2009, Springer Science + Business Media

    Dr Juul T Wijnen

  48. Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2009, American Association for Cancer Research (AACR)

    Dr Juul T Wijnen

  49. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

    Article • Familial Cancer, September 2009, Springer Science + Business Media

    Dr Juul T Wijnen

  50. Disentangling the Babylonian speech confusion in genetic counseling: An analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic

    Article • Genetics in Medicine, September 2009, Springer Science + Business Media

    Dr Juul T Wijnen, Professor Aad Tibben

  51. A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example

    Article • BMC Cancer, June 2009, Springer Science + Business Media

    Dr Juul T Wijnen

  52. Introduction to molecular and clinical genetics of colorectal cancer syndromes

    Article • Best Practice & Research Clinical Gastroenterology, April 2009, Elsevier

    Dr Juul T Wijnen

  53. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history

    Article • February 2009, Springer Science + Business Media

    Dr Juul T Wijnen

  54. Intronic variants inBRCA1andBRCA2that affect RNA splicing can be reliably selected by splice-site prediction programs

    Article • Human Mutation, January 2009, Wiley

    Dr Juul T Wijnen

  55. Chromosome 8q23.3 and 11q23.1 Variants Modify Colorectal Cancer Risk in Lynch Syndrome

    Article • Gastroenterology, January 2009, Elsevier

    Dr Juul T Wijnen

  56. No evidence that GATA3 rs570613 SNP modifies breast cancer risk

    Article • Breast Cancer Research and Treatment, December 2008, Springer Science + Business Media

    Dr Juul T Wijnen

  57. High frequency of copy-neutral LOH inMUTYH-associated polyposis carcinomas

    Article • The Journal of Pathology, September 2008, Wiley

    Dr Juul T Wijnen

  58. Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer

    Article • Human Molecular Genetics, August 2008, Oxford University Press (OUP)

    Dr Juul T Wijnen

  59. CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer

    Article • Clinical Cancer Research, August 2008, American Association for Cancer Research (AACR)

    Dr Juul T Wijnen

  60. Deciphering the genetics of hereditary non-syndromic colorectal cancer

    Article • European Journal of Human Genetics, July 2008, Springer Science + Business Media

    Dr Juul T Wijnen

  61. Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas

    Article • Familial Cancer, April 2008, Springer Science + Business Media

    Dr Juul T Wijnen

  62. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome

    Article • International Journal of Cancer, April 2008, Wiley

    Dr Juul T Wijnen

  63. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

    Article • Nature Genetics, March 2008, Springer Science + Business Media

    Dr Juul T Wijnen

  64. Desmoid Tumors in a Dutch Cohort of Patients With Familial Adenomatous Polyposis

    Article • Clinical Gastroenterology and Hepatology, February 2008, Elsevier

    Dr Juul T Wijnen

  65. Guidelines for the clinical management of familial adenomatous polyposis (FAP)

    Article • Gut, January 2008, BMJ

    Dr Juul T Wijnen

  66. Somatic APC mosaicism: an underestimated cause of polyposis coli

    Article • Gut, May 2007, BMJ

    Dr Juul T Wijnen

  67. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis

    Article • Clinical Genetics, May 2007, Wiley

    Dr Juul T Wijnen

  68. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

    Article • Journal of Medical Genetics, February 2007, BMJ

    Dr Juul T Wijnen

  69. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family

    Article • Familial Cancer, October 2006, Springer Science + Business Media

    Dr Juul T Wijnen

  70. Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians

    Article • CA A Cancer Journal for Clinicians, July 2006, Wiley

    Dr Juul T Wijnen

  71. Heterozygous Mutations in PMS2 Cause Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome)

    Article • Gastroenterology, February 2006, Elsevier

    Dr Juul T Wijnen

  72. Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures

    Article • Familial Cancer, November 2005, Springer Science + Business Media

    Dr Juul T Wijnen

  73. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genesMSH2,MLH1,MSH6, andPMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)

    Article • Genes Chromosomes and Cancer, January 2005, Wiley

    Dr Juul T Wijnen

  74. Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Dr Juul T Wijnen

  75. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC

    Article • Gastroenterology, January 2004, Elsevier

    Dr Juul T Wijnen

  76. Identification of HNPCC by Molecular Analysis of Colorectal and Endometrial Tumors

    Article • Disease Markers, January 2004, Hindawi Publishing Corporation

    Dr Juul T Wijnen

  77. Molecular Analysis of Hereditary Nonpolyposis Colorectal Cancer in the United States: High Mutation Detection Rate among Clinically Selected Families and Characterization of an American Founder Genomic Deletion of the MSH2 Gene

    Article • The American Journal of Human Genetics, May 2003, Elsevier

    Dr Juul T Wijnen

  78. The CHEK2 1100delC Mutation Identifies Families with a Hereditary Breast and Colorectal Cancer Phenotype

    Article • The American Journal of Human Genetics, May 2003, Elsevier

    Dr Juul T Wijnen

  79. Immunohistochemical expression (IHC) and microsatellite instability (MSI) analysis in families with clustering of colorectal cancer

    Article • Gastroenterology, April 2003, Elsevier

    Dr Juul T Wijnen

  80. Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum

    Article • American Journal of Medical Genetics Part A, March 2003, Wiley

    Dr Juul T Wijnen

  81. Multiple Primary Cancer, Including Transitional Cell Carcinoma of the Upper Uroepithelial Tract in a Multigeneration Hnpcc Family: Molecular Genetic, Diagnostic, and Management Implications

    Article • The American Journal of Gastroenterology, March 2003, Wolters Kluwer Health

    Dr Juul T Wijnen

  82. Conventional and Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair in Hereditary Colorectal Tumors

    Article • American Journal Of Pathology, February 2003, Elsevier

    Dr Juul T Wijnen

  83. A 10-Mb paracentric inversion of chromosome arm 2p inactivatesMSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred

    Article • Genes Chromosomes and Cancer, July 2002, Wiley

    Dr Juul T Wijnen

  84. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion

    Article • British Journal of Haematology, February 2002, Wiley

    Dr Juul T Wijnen

  85. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion

    Article • British Journal of Haematology, February 2002, Wiley

    Dr Juul T Wijnen

  86. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study

    Article • International Journal of Colorectal Disease, October 2001, Springer Science + Business Media

    Dr Juul T Wijnen

  87. Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients

    Article • Oncogene, September 2001, Springer Science + Business Media

    Dr Juul T Wijnen

  88. An update of cancer risk in HNPCC: A study of 101 families including 58 families associated with mismatch repair mutations

    Article • Gastroenterology, April 2000, Elsevier

    Dr Juul T Wijnen

  89. Colonoscopic screening of carriers of mismatch repair gene mutations: Results from the dutch HNPCC registry

    Article • Gastroenterology, April 2000, Elsevier

    Dr Juul T Wijnen

  90. Microsatellite instability (MSI) and immunohistochemical analysis of endometrial cancers as a tool to identify family members at risk for hereditary nonpolyposis colorectal cancer (HNPCC)

    Article • Gastroenterology, April 2000, Elsevier

    Dr Juul T Wijnen

  91. Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach

    Article • European Journal of Human Genetics, January 2000, Springer Science + Business Media

    Dr Juul T Wijnen

  92. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

    Article • The Journal of Pathology, January 2000, Wiley

    Dr Juul T Wijnen

  93. Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer

    Article • Genes Chromosomes and Cancer, January 2000, Wiley

    Dr Juul T Wijnen

  94. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked toBRCA1, fails to support a role forBRCA1 in colorectal tumorigenesis

    Article • International Journal of Cancer, January 2000, Wiley

    Dr Juul T Wijnen

  95. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing

    Article • International Journal of Cancer, August 1999, Wiley

    Dr Juul T Wijnen

  96. Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association?

    Article • European Journal of Human Genetics, June 1999, Springer Science + Business Media

    Dr Juul T Wijnen

  97. Suspected hereditary nonpolyposis colorectal cancer

    Article • Diseases of the Colon & Rectum, June 1999, Wolters Kluwer Health

    Dr Juul T Wijnen

  98. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer

    Article • Cytogenetic and Genome Research, January 1999, Karger Publishers

    Dr Juul T Wijnen

  99. Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1998, New England Journal of Medicine (NEJM/MMS)

    Dr Juul T Wijnen

  100. Familial and Hereditary Non-polyposis Colorectal Cancer: Issues Relevant for Surgical Practice

    Article • January 1998, Springer Science + Business Media

    Dr Juul T Wijnen

  101. Hereditary Nonpolyposis Colorectal Cancer Families Not Complying with the Amsterdam Criteria Show Extremely Low Frequency of Mismatch-Repair-Gene Mutations

    Article • The American Journal of Human Genetics, August 1997, Elsevier

    Dr Juul T Wijnen

  102. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis

    Article • Human Mutation, January 1997, Wiley

    Dr Juul T Wijnen

  103. Molecular analysis of theAPC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis

    Article • Human Mutation, January 1997, Wiley

    Dr Juul T Wijnen

  104. Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene

    Article • Human Genetics, September 1996, Springer Science + Business Media

    Dr Juul T Wijnen

  105. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis

    Article • Gastroenterology, April 1996, Elsevier

    Dr Juul T Wijnen

  106. Linkage studies on hereditary nonpolyposis colorectal cancer in the Netherlands

    Article • Cancer Genetics and Cytogenetics, October 1994, Elsevier

    Dr Juul T Wijnen

  107. Endometrial Cancer in Four Sisters: Report of a Kindred with Presumed Cancer Family Syndrome

    Article • Gynecologic Oncology, August 1994, Elsevier

    Dr Juul T Wijnen

  108. DGGE polymorphism in intron 10 of MSH2, the HNPCC gene

    Article • Human Molecular Genetics, January 1994, Oxford University Press (OUP)

    Dr Juul T Wijnen

  109. Paternal duplication of chromosome 5q11.2–5q14 in a male born with craniostenosis, ear tags, kidney dysplasia and several other anomalies

    Article • Human Genetics, November 1993, Springer Science + Business Media

    Dr Juul T Wijnen

  110. Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis

    Article • Genomics, August 1992, Elsevier

    Dr Juul T Wijnen

  111. Dr. McDermott and Associates Reply

    Article • American Journal of Psychiatry, June 1992, American Psychiatric Association

    Dr Juul T Wijnen

  112. Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation

    Article • British Journal of Haematology, October 1991, Wiley

    Dr Juul T Wijnen

  113. A new deletion polymorphism at D5S71 raises the linkage information on adenomatous polyposis coli: implications for presymptomatic diagnosis

    Article • Human Genetics, February 1991, Springer Science + Business Media

    Dr Juul T Wijnen

  114. CA repeat polymorphism from YAC JW25 at the D5S318 locus, distal to adenomatous polyposis coli (APC)

    Article • Nucleic Acids Research, January 1991, Oxford University Press (OUP)

    Dr Juul T Wijnen

  115. Human αB-crystallin (CRYA2) gene mapped to chromosome 11q12-q23

    Article • Human Genetics, July 1990, Springer Science + Business Media

    Dr Juul T Wijnen

  116. Assignment of the human gene for histidine-rich glycoprotein to chromosome 3

    Article • Genomics, June 1990, Elsevier

    Dr Juul T Wijnen

  117. Solid-phase adsorption of antigens for efficient production of antibodies reactive with native and fixed tissue antigens

    Article • Journal of Immunological Methods, February 1990, Elsevier

    Dr Juul T Wijnen

  118. Linkage Studies on Familial Adenomatous Polyposis in the Netherlands

    Article • January 1990, Springer Science + Business Media

    Dr Juul T Wijnen

  119. Vector-Alu PCR: a rapid step in mapping cosmids and YACs

    Article • Nucleic Acids Research, January 1990, Oxford University Press (OUP)

    Dr Juul T Wijnen

  120. Distribution of adenosine deaminase complexing protein (ADCP) in human tissues.

    Article • Journal of Histochemistry & Cytochemistry, December 1989, SAGE Publications

    Dr Juul T Wijnen

  121. PRESYMPTOMATIC DIAGNOSIS OF FAMILIAL ADENOMATOUS POLYPOSIS BY BRIDGING DNA MARKERS

    Article • The Lancet, December 1989, Elsevier

    Dr Juul T Wijnen

  122. Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in dutch families

    Article • Genomics, July 1989, Elsevier

    Dr Juul T Wijnen

  123. Structure of the bovine eye lens γs-crystallin gene (formerly βs)

    Article • Gene, May 1989, Elsevier

    Dr Juul T Wijnen

  124. Prevalence and molecular heterogeneity of alfa+thalassemia in two tribal populations from Andhra Pradesh, India

    Article • Human Genetics, October 1988, Springer Science + Business Media

    Dr Juul T Wijnen

  125. Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22

    Article • Human Genetics, June 1988, Springer Science + Business Media

    Dr Juul T Wijnen

  126. Human ?-globin maps to pter-p13.3 in chromosome 16 distal to PGP

    Article • Human Genetics, July 1987, Springer Science + Business Media

    Dr Juul T Wijnen

  127. G6PD Punjab, a dialysis sensitive variant of human glucose-6-phosphate dehydrogenase

    Article • Journal of Genetics, April 1987, Springer Science + Business Media

    Dr Juul T Wijnen

  128. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene

    Article • Nucleic Acids Research, January 1987, Oxford University Press (OUP)

    Dr Juul T Wijnen

  129. Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8

    Article • Human Genetics, February 1986, Springer Science + Business Media

    Dr Juul T Wijnen

  130. G6PD VARIATION IN INDIA11The study was performed within the frame work of the project 5.A.12 (“Genetics of Human Enzymes”) of the Medical Faculty at the State University of Leiden and supported by grants from WHO, IBP (the Dutch Branch) and FUNGO which...

    Article • January 1986, Elsevier

    Dr Juul T Wijnen

  131. Adenosine Deaminase Complexing Protein in Transformed Cells and Colon Cancera

    Article • Annals of the New York Academy of Sciences, October 1985, Wiley

    Dr Juul T Wijnen

  132. Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity

    Article • The Histochemical Journal, January 1985, Springer Science + Business Media

    Dr Juul T Wijnen

  133. Maturation Dependent Changes in Nucleoside Phosphorylase (NP), Adenosine Deaminase (ADA) and Ada Complexing Protein (ADCP) in Intestinal Epithelial Cells

    Article • January 1985, Elsevier

    Dr Juul T Wijnen

  134. Adenosine Deaminase (ADA; E.C. no. 3.5.4.4.) in Colorectal Adenocarcinoma in Man

    Article • January 1984, Springer Science + Business Media

    Dr Juul T Wijnen

  135. Adenosine Deaminase Complexing Protein: A Transformation Sensitive Marker and Possible Tool in Immunodiagnosis of Solid Tumors

    Article • January 1984, Elsevier

    Dr Juul T Wijnen

  136. Electrophoretic characterization and genetics of human biliverdin reductase (BLVR; EC 1.3.1.24); assignment of BLVR to the p14 → cen region of human chromosome 7 in mouse-human somatic cell hybrids

    Article • Biochemical Genetics, February 1983, Springer Science + Business Media

    Dr Juul T Wijnen

  137. Electrophoretic characterization and genetics of human biliverdin reductase (BLVR; EC 1.3.1.24); assignment of BLVR to the p14 → cen region of human chromosome 7 in mouse-human somatic cell hybrids

    Article • Biochemical Genetics, February 1983, Springer Science + Business Media

    Dr Juul T Wijnen

  138. Glutathione S-Transferase Activity in Human Fetal and Adult Tissues

    Article • Pharmacology, January 1981, Karger Publishers

    Dr Juul T Wijnen